Bridgewater, NJ – According to filings with the U.S. Securities and Exchange Commission, Jogo Health is raising $2,600,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Sanjai Murali played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Jogo Health
JOGO is a prescription digital therapeutics product to treat pain and neuromuscular conditions. JOGO helps enhance rewiring of the CNS to improve voluntary control muscles that was lost due to stroke and other neuro-muscular conditions. JOGO is composed of wearable wireless s/EMG sensors, and a patent protected Mobile App that provide treatment protocols and games that can be adapted for muscle relaxation, movement coordination, and neuro-muscular reeducation, all leveraging neuroplasticity.

To learn more about Jogo Health, visit http://www.jogohealth.com/

Contact:
Sanjai Murali, Chief Executive Officer
908-291-2043
sanjai@jogohealth.com
https://www.linkedin.com/in/sanjai-murali-3990371/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved